Athena operates in the field of human cell therapies using the latest technologies for the production of Advanced Therapy Medicines (ATMP) and point-of-care Autologous Cell Transplants.

The staff, integrating experience and know-how through an external network of scientific collaborations, produces information, training and technical solutions for specific therapeutic needs

Events and Partecipation

Giornate di Chirurgia Vascolare

Hotel Ariston Paestum Salerno 19-20 Maggio 2023
...
Read More »

Programs and Strategies For Limbs Preservation

Aula 6-Polo Didattico Arcispedale "Sant'Anna di Cona" Ferrara 14 Aprile 2023
...
Read More »

Wound Care Update 2023

Padova March 10, 2023
...
Read More »

1st NOTA Annual Meeting

Centro Biotecnologie Molecolari MBC Via Nizza, 52 Torino 30-31 Marzo 2023
...
Read More »

La Gestione delle Complicanze agli Arti Inferiori nel Diabete Mellito

Pisa, Hotel San Ranieri 20-22 Marzo 2023
...
Read More »

Piede Diabetico tra Innovazione e Real life

Villa Crawford, Sorrento (NA) 29 October 2022
Read More »

Aortic Surgery Peripheral & Venous 2022

Università Vita-Salute San Raffaele, Milano 15, 16, 17 December 2022
...
Read More »

Piede Diabetico-Update 2022

Faculty of Medicine and Surgery, University of Rome Tor Vergata, Aula Bovet Saturday 17 December 2022
...
Read More »

Athena is present with its therapeutic solutions in laboratories and in more than 40 Italian hospitals, university clinics and I.R.C.S. (Scientific Hospitalization and Treatment Institutes)

SEXTON BIOTECHNOLOGIES

Sexton Biotechnologies is a  biotechnology company focused on the development and sales of bioproduction tools for cell and gene therapy, located in Indianapolis, INDIANA (USA).

Sexton develops purpose-built CGT tools and media to enable flexible automation and scaling of cell manufacturing processes to increase the probability of positive clinical outcomes and reduce time-to-market, failure points, and labor costs. Sexton’s portfolio includes the CellSeal platform of cryo-storage tools and fill/finish systems and human platelet lysate growth supplements

HemaTrate® Blood Filtration system

HemaTrate® Blood Filtration System is designed for use in the clinical laboratory, or intra-operatively at the point of care, for the rapid preparation of a total nucleated cell concentrate (TNC) from 20-120 ml of anticoagulated blood for use in human cell therapy applications.

The HemaTrate® Blood Filtration System device is contained in the HemaTrate® Procedure Pack produced by Betatex Spa on Athena specifications. HemaTrate® Procedure Pack is a sterile, assembled kit complete with required accessories for product use, supporting consistent procedural technique while considering the patient’s biological variable.

SYMATESE - NEVELIA® Bi-Layer Matrix

NEVELIA® Bi-Layer Matrix is a matrix that serves as a support (scaffold) for the infiltration of patient cells and thus contributes to the natural process of tissue regeneration. The medical grade silicone layer consists of a silicone elastomer reinforced with a polyester material, which acts as a ‘pseudo-epidermis’, protecting the wound from bacterial infection and other damage

Scroll to Top